Vildagliptin Glycemic Profiles Assessment Using a Continuous Glucose Monitoring Device.
Clinical trial NCT01262586 · COMPLETED
Trial details
- NCT number
- NCT01262586
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-01
- Primary completion
- 2011-03-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.